Krsnaa Diagnostics Q4 FY26 PAT jumps 102% to ₹41.72cr

Why Krsnaa Diagnostics’ Q4 numbers matter

Krsnaa Diagnostics Ltd, a diagnostics service provider in India, reported a sharp jump in profitability for the quarter ended March 2026 (Q4 FY25-26). Net profit for the quarter rose 101.74% year-on-year to ₹41.72 crore, and the company also posted a steep improvement compared with the prior quarter. The quarter is notable because it combines steady operating profit with an outsized rise in other income, which lifted profit before tax and net profit.

Alongside the results, the company has an upcoming earnings date of 13 August 2026, when it is expected to report results for the quarter ended June 30, 2026. Investors will also track how management’s FY27 plans, including the Rajasthan project and radiology expansion, shape near-term margins and cash outflows.

Headline profit: up 102% YoY and 174% QoQ

Krsnaa Diagnostics’ net profit (attributable to owners) for Q4 FY26 stood at ₹41.718 crore, up from ₹20.678 crore in Q4 FY25. The same metric also rose sequentially from ₹15.246 crore in Q3 FY26, translating into a 173.63% quarter-on-quarter increase as cited in the data.

In the quarterly P&L table for March 2026, profit after tax is reported at ₹43.38 crore. The narrative dataset separately states net profit attributable to owners at ₹41.718 crore for the quarter. Both figures point to a materially stronger quarter versus the previous year and the immediately preceding quarter.

What changed in Q4 FY26: other income stood out

For Q4 FY26 (Mar 2026), net sales were ₹173.02 crore versus ₹159.43 crore in Dec 2025. Operating profit improved to ₹56.83 crore from ₹47.68 crore in the previous quarter, indicating healthier operational performance during the period.

The biggest swing factor was other income, which rose to ₹31.41 crore in Mar 2026 from ₹3.80 crore in Dec 2025. With interest cost at ₹11.86 crore and depreciation at ₹22.25 crore for the quarter, the elevated other income helped lift profit before tax to ₹54.13 crore. Tax for the quarter was ₹10.75 crore, and profit after tax in the quarterly table was ₹43.38 crore.

Quarterly financial snapshot (₹ crore)

The table below summarises the quarterly trend presented in the source data.

Total income growth: Q4 FY26 at ₹204.42 crore

The company’s total income for Q4 FY26 was reported at ₹204.424 crore, up 14.13% year-on-year from ₹179.109 crore in Q4 FY25. On a sequential basis, total income increased 25.24% from ₹163.227 crore in Q3 FY26.

For the full year FY26, consolidated total income was ₹816.164 crore, up 9.89% year-on-year from ₹742.695 crore in FY25. Annual standalone net profit for FY26 was ₹102.675 crore, up 23.99% year-on-year from ₹82.808 crore in the previous year, as per the data provided.

Dividend: ₹2.75 per share for FY ended March 2025

For the quarter ending March 2025, the company declared a dividend of ₹2.75 per share, with the dataset noting a dividend yield of 0.91%. The same information also appears as a final dividend recommendation for the financial year ended March 31, 2025, subject to shareholder approval at the AGM.

The source content includes two reported dates for the ₹2.75 dividend (12 May 2025 and 12 Sep 2025). Separately, for FY25-26, the Board recommended a final dividend of ₹2 per equity share of face value ₹5 (40% of face value).

Rajasthan project: FY27 revenue guidance and capex plans

Management revised its FY27 guidance for the Rajasthan project to revenue in the range of ₹100-150 crore, citing uncertainties around the ramp-up phase. The plan assumes full installation by Q2 FY27, with a conservative ramp-up.

The company also outlined an FY27 investment plan of ₹530 crore towards fixed assets for the Rajasthan project and radiology expansion. It indicated an effort to sustain EBITDA margins at current levels, while acknowledging expected short-term pressure linked to manpower deployment in Rajasthan during Q1.

Market snapshot: price, market cap, and earnings calendar

As per the provided data, Krsnaa Diagnostics’ share price was ₹560.85, and the market capitalisation was ₹1,819.32291912 crore, calculated using the latest share price.

The last earnings date is listed as Q4 FY25-26 on 25 May 2026. The upcoming earnings date is Q1 FY26-27 on 13 August 2026, and the company is expected to discuss financial results for the quarter ended June 30, 2026.

Key data points at a glance (₹ crore unless stated)

What investors may track next

The Q4 FY26 outcome shows that quarterly profit can be influenced significantly by movements in other income, as seen in Mar 2026. With a large FY27 capex plan (₹530 crore) and an execution-heavy Rajasthan rollout that is expected to be fully installed by Q2 FY27, near-term performance updates are likely to be closely watched.

The next formal checkpoint is 13 August 2026, when the company is expected to report Q1 FY26-27 results and discuss performance for the quarter ended June 30, 2026. Any updates on the Rajasthan ramp-up and margin trajectory, within the company’s stated targets and near-term pressures, will be central to that discussion.